-
Syros Pharmaceuticals (NASDAQ:SYRS) Earns Buy Rating from HC Wainwright
ソース: Buzz FX / 01 11 2024 08:46:15 America/New_York
Syros Pharmaceuticals (NASDAQ:SYRS) Earns Buy Rating from HC Wainwright Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Syros Pharmaceuticals ( NASDAQ:SYRS - Get Free Report ) 's stock had its "buy" rating reiterated
Read more...